Skip to main content
Top
Published in: Rheumatology International 5/2011

01-05-2011 | Original Article

Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients

Authors: Serpil Muge Deger, Mehmet Akif Ozturk, Mehmet D. Demirag, Selcuk Aslan, Berna Goker, Seminur Haznedaroglu, A. Mesut Onat

Published in: Rheumatology International | Issue 5/2011

Login to get access

Abstract

The aim of the present study was to investigate the health-related quality of life (HRQOL) and mood conditions in familial Mediterranean fever (FMF) patients. Ninety FMF patients (F/M 60/30, median age 29) and 67 control subjects (F/M 46/21, median age 30) were included in this study. HRQOL was assessed with short form-36 (SF-36) and mood conditions were assessed with hospital anxiety depression scale (HADS). FMF patients had significantly lower mean scores on SF-36 physical components compared to the control group. However, mental components were comparable between groups. FMF patients were significantly more likely to have depression and anxiety compared to the control group [30 (33%) vs. 8 (12%), respectively, χ 2 = 9.58, OR (95% CI) = 3.7 (1.5–8.7), p < 0.01 for depression and 48 (53%) and 11 (16%), respectively, χ 2 = 22.31, OR (95% CI) = 5.8 (2.7–12.5), p < 0.001 for anxiety]. When frequency of anxious subjects was adjusted for the presence of concomitant depressive status as a confounding factor, the difference between the groups remained statistically significant [χ 2 = 11.86, OR (95% CI) = 5.4 (2.1–13.7), p < 0.01]. However, the difference of depression status between groups was not statistically significant when adjusted for the presence of concomitant anxiety status [χ 2 = 0.08, OR (95% CI) = 1.3 (0.5–3.8), p = 0.78] and FMF was found to be independently associated with only anxiety [OR (95% CI) = 7.1 (2.3–20.3)]. In addition, pure anxious FMF subgroup had significantly lower scores of mental health and mental component summary when compared to normal mood subgroup. In conclusion, FMF might adversely affect HRQOL. Depression and anxiety are more frequent in FMF patients than healthy subjects.
Literature
1.
go back to reference Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P, Rasmussen NK, Bullinger M, Fukuhara S, Kaasa S, Leplège A, IQOLA Project Group (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 13:283–298PubMedCrossRef Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, Mosconi P, Rasmussen NK, Bullinger M, Fukuhara S, Kaasa S, Leplège A, IQOLA Project Group (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 13:283–298PubMedCrossRef
2.
go back to reference Benton T, Staab J, Evans DL (2007) Medical co-morbidity in depressive disorders. Ann Clin Psychiatry 19:289–303PubMedCrossRef Benton T, Staab J, Evans DL (2007) Medical co-morbidity in depressive disorders. Ann Clin Psychiatry 19:289–303PubMedCrossRef
3.
go back to reference Stoudemire A (1996) Epidemiology and psychopharmacology of anxiety in medical patients. J Clin Psychiatry 57(Suppl 7):64–72 73–75PubMed Stoudemire A (1996) Epidemiology and psychopharmacology of anxiety in medical patients. J Clin Psychiatry 57(Suppl 7):64–72 73–75PubMed
4.
go back to reference Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872–878PubMedCrossRef Isik A, Koca SS, Ozturk A, Mermi O (2007) Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 26:872–878PubMedCrossRef
5.
go back to reference Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA (2005) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 32:1459–1466PubMed Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA (2005) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 32:1459–1466PubMed
6.
go back to reference Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA (2006) Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 45:1288–1293CrossRef Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA (2006) Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 45:1288–1293CrossRef
7.
go back to reference Mancuso CA, Peterson MG, Charlson ME (2000) Effects of depressive symptoms on health related quality of life in asthma patients. J Gen Intern Med 15:301–310PubMedCrossRef Mancuso CA, Peterson MG, Charlson ME (2000) Effects of depressive symptoms on health related quality of life in asthma patients. J Gen Intern Med 15:301–310PubMedCrossRef
8.
go back to reference Ozcetin A, Ataoglu S, Kocer E, Yazici S, Yildiz O, Ataoglul A, Icmeli C (2007) Effects of depression and anxiety on quality of life of patients with rheumatoid arthritis, knee osteoarthritis and fibromyalgia syndrome. West Indian Med J 56:122–129PubMedCrossRef Ozcetin A, Ataoglu S, Kocer E, Yazici S, Yildiz O, Ataoglul A, Icmeli C (2007) Effects of depression and anxiety on quality of life of patients with rheumatoid arthritis, knee osteoarthritis and fibromyalgia syndrome. West Indian Med J 56:122–129PubMedCrossRef
9.
go back to reference Keystone E, Burmester GR, Furie R, Loveless JE, Emery P, Kremer J, Tak PP, Broder MS, Yu E, Cravets M, Magrini F, Jost F (2008) Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum 59:785–793PubMedCrossRef Keystone E, Burmester GR, Furie R, Loveless JE, Emery P, Kremer J, Tak PP, Broder MS, Yu E, Cravets M, Magrini F, Jost F (2008) Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum 59:785–793PubMedCrossRef
10.
go back to reference Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr, ATLAS Study Group (2008) Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). J Rheumatol 35:1346–1353PubMed Revicki DA, Luo MP, Wordsworth P, Wong RL, Chen N, Davis JC Jr, ATLAS Study Group (2008) Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). J Rheumatol 35:1346–1353PubMed
11.
go back to reference Ozen S (1999) New interest in an old disease: familial Mediterranean fever. Clin Exp Rheumatol 17:745–749PubMed Ozen S (1999) New interest in an old disease: familial Mediterranean fever. Clin Exp Rheumatol 17:745–749PubMed
12.
go back to reference Ozcakar L, Onat AM, Kaymak SU, Ureten K, Akinci A (2005) Selective serotonin reuptake inhibitors in familial Mediterranean fever: are we treating depression or inflammation? Rheumatol Int 25:319–320PubMedCrossRef Ozcakar L, Onat AM, Kaymak SU, Ureten K, Akinci A (2005) Selective serotonin reuptake inhibitors in familial Mediterranean fever: are we treating depression or inflammation? Rheumatol Int 25:319–320PubMedCrossRef
13.
go back to reference Onat AM, Oztürk MA, Ozçakar L, Ureten K, Kaymak SU, Kiraz S, Ertenli I, Calgüneri M (2007) Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever. Tohoku J Exp Med 211:9–14PubMedCrossRef Onat AM, Oztürk MA, Ozçakar L, Ureten K, Kaymak SU, Kiraz S, Ertenli I, Calgüneri M (2007) Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever. Tohoku J Exp Med 211:9–14PubMedCrossRef
14.
go back to reference Onat AM, Ozçakar L, Oztürk MA, Uçar G, Ureten K, Dagli N, Kiraz S, Ertenli I, Calgüneri M (2007) Plasma and platelet serotonin levels in familial Mediterranean fever. Clin Exp Rheumatol 25(4 Suppl 45):S16–S20PubMed Onat AM, Ozçakar L, Oztürk MA, Uçar G, Ureten K, Dagli N, Kiraz S, Ertenli I, Calgüneri M (2007) Plasma and platelet serotonin levels in familial Mediterranean fever. Clin Exp Rheumatol 25(4 Suppl 45):S16–S20PubMed
15.
go back to reference Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12(Suppl 1):2–19PubMedCrossRef Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12(Suppl 1):2–19PubMedCrossRef
16.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRef
17.
go back to reference Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef
18.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef
19.
go back to reference Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33(4 Suppl):264–279 Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33(4 Suppl):264–279
20.
go back to reference Olssøn I, Mykletun A, Dahl AA (2005) The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46PubMedCrossRef Olssøn I, Mykletun A, Dahl AA (2005) The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry 5:46PubMedCrossRef
21.
go back to reference Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14:259–264PubMedCrossRef Pinar R (2005) Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 14:259–264PubMedCrossRef
22.
go back to reference Aydemir O (1997) Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale. Turk Psikiyatri Derg 8:280–287 Aydemir O (1997) Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale. Turk Psikiyatri Derg 8:280–287
23.
go back to reference Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A (2007) Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol, article ID: 76396 Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, Sanisoglu SY, Yesilova Z, Ozmenler N, Ozsahin A, Sengul A (2007) Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol, article ID: 76396
24.
go back to reference Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M (2003) Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54:566–572PubMedCrossRef Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M (2003) Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54:566–572PubMedCrossRef
25.
go back to reference Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106:249–255PubMedCrossRef Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Dik MG, Hack CE, Hoogendijk WJ (2008) Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106:249–255PubMedCrossRef
26.
go back to reference Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170:429–433CrossRef Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170:429–433CrossRef
27.
go back to reference Merendino RA, Di Rosa AE, Di Pasquale G, Minciullo PL, Mangraviti C, Costantino A, Ruello A, Gangemi S (2002) Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm 11:265–267PubMedCrossRef Merendino RA, Di Rosa AE, Di Pasquale G, Minciullo PL, Mangraviti C, Costantino A, Ruello A, Gangemi S (2002) Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm 11:265–267PubMedCrossRef
28.
go back to reference Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452PubMedCrossRef Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452PubMedCrossRef
29.
go back to reference von Känel R, Hepp U, Kraemer B, Traber R, Keel M, Mica L, Schnyder U (2007) Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 41:744–752CrossRef von Känel R, Hepp U, Kraemer B, Traber R, Keel M, Mica L, Schnyder U (2007) Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 41:744–752CrossRef
30.
go back to reference Uguz F, Akman C, Kucuksarac S, Tufekci O (2009) Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 63:50–55PubMedCrossRef Uguz F, Akman C, Kucuksarac S, Tufekci O (2009) Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 63:50–55PubMedCrossRef
31.
go back to reference Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, Gulsen M, Karaeren N, Dagalp K (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRef Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, Gulsen M, Karaeren N, Dagalp K (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRef
32.
go back to reference Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811PubMedCrossRef Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A (2007) Serum proinflammatory cytokines directing T helper 1 polarization in patients with familial Mediterranean fever. Rheumatol Int 27:807–811PubMedCrossRef
33.
go back to reference Haznedaroglu S, Ozturk MA, Sancak B, Goker B, Onat AM, Bukan N, Ertenli I, Kiraz S, Calguneri M (2005) Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 23(4 Suppl 38):S77–S80PubMed Haznedaroglu S, Ozturk MA, Sancak B, Goker B, Onat AM, Bukan N, Ertenli I, Kiraz S, Calguneri M (2005) Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 23(4 Suppl 38):S77–S80PubMed
34.
go back to reference Erken E, Ozer HT, Gunesacar R (2006) Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatol Int 26:862–864PubMedCrossRef Erken E, Ozer HT, Gunesacar R (2006) Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatol Int 26:862–864PubMedCrossRef
35.
go back to reference Buskila D, Zaks N, Neumann L, Livneh A, Greenberg S, Pras M, Langevitz P (1997) Quality of life of patients with familial Mediterranean fever. Clin Exp Rheumatol 15:355–360PubMed Buskila D, Zaks N, Neumann L, Livneh A, Greenberg S, Pras M, Langevitz P (1997) Quality of life of patients with familial Mediterranean fever. Clin Exp Rheumatol 15:355–360PubMed
36.
go back to reference Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCrossRef Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCrossRef
37.
go back to reference Akar S, Can G, Binicier O, Aksu K, Akinci B, Solmaz D, Birlik M, Keser G, Akkoc N, Onen F (2008) Quality of life in patients with Takayasu’s arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 27:859–865PubMedCrossRef Akar S, Can G, Binicier O, Aksu K, Akinci B, Solmaz D, Birlik M, Keser G, Akkoc N, Onen F (2008) Quality of life in patients with Takayasu’s arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 27:859–865PubMedCrossRef
38.
go back to reference Kuriya B, Gladman DD, Ibañez D, Urowitz MB (2008) Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 59:181–185PubMedCrossRef Kuriya B, Gladman DD, Ibañez D, Urowitz MB (2008) Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 59:181–185PubMedCrossRef
39.
go back to reference Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P (1996) Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 53:889–895PubMed Sherbourne CD, Wells KB, Meredith LS, Jackson CA, Camp P (1996) Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 53:889–895PubMed
40.
go back to reference Saharinen T, Hintikka J, Niskanen L, Kylmä J, Honkalampi K, Nikkonen M, Haatainen K, Koivumaa-Honkanen H, Viinamäki H (2008) Health-related quality of life in a population-based sample of men with long-term mental symptoms. Nord J Psychiatry 62:106–112PubMedCrossRef Saharinen T, Hintikka J, Niskanen L, Kylmä J, Honkalampi K, Nikkonen M, Haatainen K, Koivumaa-Honkanen H, Viinamäki H (2008) Health-related quality of life in a population-based sample of men with long-term mental symptoms. Nord J Psychiatry 62:106–112PubMedCrossRef
Metadata
Title
Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients
Authors
Serpil Muge Deger
Mehmet Akif Ozturk
Mehmet D. Demirag
Selcuk Aslan
Berna Goker
Seminur Haznedaroglu
A. Mesut Onat
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1334-4

Other articles of this Issue 5/2011

Rheumatology International 5/2011 Go to the issue